Bordoni L, Jimenez E, Nielsen S, Østergaard L, Frische S. A new experimental mouse model of water intoxication with sustained increased intracranial pressure and mild hyponatremia without side effects of antidiuretics. Exp Anim. 2020;69:92-103 pubmed publisher

Probst S, Scharner B, McErlean R, Lee W, Thevenod F. Inverse Regulation of Lipocalin-2/24p3 Receptor/SLC22A17 and Lipocalin-2 Expression by Tonicity, NFAT5/TonEBP and Arginine Vasopressin in Mouse Cortical Collecting Duct Cells mCCD(cl.1): Implications for Osmotolerance. Int J Mol Sci. 2019;20: pubmed publisher

Lehmann M, Ashworth K, Manco Johnson M, Di Paola J, Neeves K, Ng C. Evaluation of a microfluidic flow assay to screen for von Willebrand disease and low von Willebrand factor levels. J Thromb Haemost. 2017;: pubmed publisher

Chen Z, Sellergren B, Shen X. Synergistic Catalysis by "Polymeric Microzymes and Inorganic Nanozymes": The 1+1>2 Effect for Intramolecular Cyclization of Peptides. Front Chem. 2017;5:60 pubmed publisher

Li W, Jin W, Tsuji K, Chen Y, Nomura N, Su L, et al. Ezrin directly interacts with AQP2 and promotes its endocytosis. J Cell Sci. 2017;130:2914-2925 pubmed publisher

Orlov D, McCluskey S, Callum J, Rao V, Moreno J, Karkouti K. Utilization and Effectiveness of Desmopressin Acetate After Cardiac Surgery Supplemented With Point-of-Care Hemostatic Testing: A Propensity-Score-Matched Analysis. J Cardiothorac Vasc Anesth. 2017;31:883-895 pubmed publisher

Blankenstein K, Borschewski A, Labes R, Paliege A, Boldt C, McCormick J, et al. Calcineurin inhibitor cyclosporine A activates renal Na-K-Cl cotransporters via local and systemic mechanisms. Am J Physiol Renal Physiol. 2017;312:F489-F501 pubmed publisher

Ma J, Zhang Z, Yang L, Kriston Vizi J, Cutler D, Li W. BLOC-2 subunit HPS6 deficiency affects the tubulation and secretion of von Willebrand factor from mouse endothelial cells. J Genet Genomics. 2016;43:686-693 pubmed publisher

Yoshioka W, Kawaguchi T, Nishimura N, Akagi T, Fujisawa N, Yanagisawa H, et al. Polyuria-associated hydronephrosis induced by xenobiotic chemical exposure in mice. Am J Physiol Renal Physiol. 2016;311:F752-F762 pubmed publisher

Ayoub M, Yvinec R, Jégot G, Dias J, Poli S, Poupon A, et al. Profiling of FSHR negative allosteric modulators on LH/CGR reveals biased antagonism with implications in steroidogenesis. Mol Cell Endocrinol. 2016;436:10-22 pubmed publisher

Gonzalez A, Cifuentes Araneda F, Ibaceta Gonzalez C, Gonzalez Vergara A, Zamora L, Henríquez R, et al. Vasopressin/V2 receptor stimulates renin synthesis in the collecting duct. Am J Physiol Renal Physiol. 2016;310:F284-93 pubmed publisher

Vassiliadi D, Tzanela M, Tsatlidis V, Margelou E, Tampourlou M, Mazarakis N, et al. Abnormal Responsiveness to Dexamethasone-Suppressed CRH Test in Patients With Bilateral Adrenal Incidentalomas. J Clin Endocrinol Metab. 2015;100:3478-85 pubmed publisher

Ekaney M, Bockmeyer C, Sossdorf M, Reuken P, Conradi F, Schuerholz T, et al. Preserved Expression of mRNA Coding von Willebrand Factor-Cleaving Protease ADAMTS13 by Selenite and Activated Protein C. Mol Med. 2015;21:355-63 pubmed publisher

Lütken S, Frøkiær J, Nielsen S. AVP-induced increase in AQP2 and p-AQP2 is blunted in heart failure during cardiac remodeling and is associated with decreased AT1R abundance in rat kidney. PLoS ONE. 2015;10:e0116501 pubmed publisher

Nørregaard R, Tao S, Nilsson L, Woodgett J, Kakade V, Yu A, et al. Glycogen synthase kinase 3α regulates urine concentrating mechanism in mice. Am J Physiol Renal Physiol. 2015;308:F650-60 pubmed publisher

Ogiwara K, Nogami K, Hosokawa K, Ohnishi T, Matsumoto T, Shima M. Comprehensive evaluation of haemostatic function in von Willebrand disease patients using a microchip-based flow chamber system. Haemophilia. 2015;21:71-80 pubmed publisher

Greilich P, Edson E, Rutland L, Jessen M, Key N, Levy J, et al. Protocol adherence when managing massive bleeding following complex cardiac surgery: a study design pilot. J Cardiothorac Vasc Anesth. 2015;29:303-10 pubmed publisher

Deipolyi A, Alexander B, Rho J, Hirsch J, Oklu R. Bilateral inferior petrosal sinus sampling using desmopressin or corticotropic-releasing hormone: a single-center experience. J Neurointerv Surg. 2015;7:690-3 pubmed publisher

Federici A, Bucciarelli P, Castaman G, Mazzucconi M, Morfini M, Rocino A, et al. The bleeding score predicts clinical outcomes and replacement therapy in adults with von Willebrand disease. Blood. 2014;123:4037-44 pubmed publisher

Ripoll G, Garona J, Pifano M, Farina H, Gomez D, Alonso D. Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model. Breast Cancer Res Treat. 2013;142:9-18 pubmed

Wafa K, Lehmann C, Wagner L, Drzymulski I, Wegner A, Pavlovic D. Desmopressin improves intestinal functional capillary density and decreases leukocyte activation in experimental endotoxemia. Microvasc Res. 2015;97:98-104 pubmed publisher

Jung H, Lim J, Choi H, Lee M, Kim J, Kim S, et al. Vasopressin V2R-targeting peptide carrier mediates siRNA delivery into collecting duct cells. PLoS ONE. 2012;7:e40010 pubmed publisher

Lee Y, Lee J, Choi H, Lim J, Jung H, Baek M, et al. E3 ubiquitin-protein ligases in rat kidney collecting duct: response to vasopressin stimulation and withdrawal. Am J Physiol Renal Physiol. 2011;301:F883-96 pubmed publisher

Wang T, Isimjan T, Chen J, Rohani S. Transparent nanostructured coatings with UV-shielding and superhydrophobicity properties. Nanotechnology. 2011;22:265708 pubmed publisher

Srichai M, Colleta H, Gewin L, Matrisian L, Abel T, Koshikawa N, et al. Membrane-type 4 matrix metalloproteinase (MT4-MMP) modulates water homeostasis in mice. PLoS ONE. 2011;6:e17099 pubmed publisher

Gabert B, Kultz D. Osmoprotective proteome adjustments in mouse kidney papilla. Biochim Biophys Acta. 2011;1814:435-48 pubmed publisher

Rao R, Patel S, Hao C, Woodgett J, Harris R. GSK3beta mediates renal response to vasopressin by modulating adenylate cyclase activity. J Am Soc Nephrol. 2010;21:428-37 pubmed publisher

Verbalis J, BARSONY J, Sugimura Y, Tian Y, Adams D, Carter E, et al. Hyponatremia-induced osteoporosis. J Bone Miner Res. 2010;25:554-63 pubmed publisher

Kim Y, Pham T, Zheng W, Hong S, BAYLIS C, Pech V, et al. Role of pendrin in iodide balance: going with the flow. Am J Physiol Renal Physiol. 2009;297:F1069-79 pubmed publisher

Dunser M, Mayr A, Ulmer H, Knotzer H, Sumann G, Pajk W, et al. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation. 2003;107:2313-9 pubmed

Saito M, Tahara A, Sugimoto T, Abe K, Furuichi K. Evidence that atypical vasopressin V(2) receptor in inner medulla of kidney is V(1B) receptor. Eur J Pharmacol. 2000;401:289-96 pubmed

Ecelbarger C, Kim G, Terris J, Masilamani S, Mitchell C, Reyes I, et al. Vasopressin-mediated regulation of epithelial sodium channel abundance in rat kidney. Am J Physiol Renal Physiol. 2000;279:F46-53 pubmed

Roald A, Tenstad O, Aukland K. The effect of AVP-V2 receptor stimulation on local GFR in the rat kidney. Acta Physiol Scand. 2000;168:351-9 pubmed

Lundin S, Folkesson H, Pierzynovski S, Bengtsson H. Gastrointestinal absorption and plasma clearance rates of [D-Arg8]vasopressin analogues in the rat. Peptides. 1994;15:809-14 pubmed

Ganz M, Boyarsky G, Sterzel R, Boron W. Arginine vasopressin enhances pHi regulation in the presence of HCO3- by stimulating three acid-base transport systems. Nature. 1989;337:648-51 pubmed